Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy

  • Jinyu Zhang (Creator)
  • Pablo Saenz Lopez Larrocha (Creator)
  • Bin Zhang (Creator)
  • Derek Wainwright (Creator)
  • Payal Dhar (Contributor)
  • Jennifer Donglan Wu (Creator)
  • Jinyu Zhang (Creator)

Dataset

Filter
Article

Search results